Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion?
Vasse
M
M
DIFEMA, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne du Rouvray, France.
Collet
J P
JP
Soria
J
J
Mirshahi
S S
SS
Vannier
J P
JP
Soria
C
C
D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D006528:Carcinoma, Hepatocellular; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis* / Q000096:biosynthesis / Q000502:physiology; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008113:Liver Neoplasms; D008222:Lymphokines / Q000494:pharmacology; D053683:Oncostatin M; D010455:Peptides / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D012307:Risk Factors; D014407:Tumor Cells, Cultured
D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; C508351:OSM protein, human; D010455:Peptides; D011994:Recombinant Proteins; D053683:Oncostatin M; D005340:Fibrinogen